Medical Care

Global Tumor Embolization Market Research Report 2025

The global market for Tumor Embolization was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Tumor Embolization is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Tumor Embolization is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Tumor Embolization in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Tumor Embolization include Boston Scientific Corporation, Varian Medical Systems, Inc., Nordion (Sotera Health), Sirtex Medical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tumor Embolization, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Embolization.
The Tumor Embolization market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tumor Embolization market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Embolization companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boston Scientific Corporation
Varian Medical Systems, Inc.
Nordion (Sotera Health)
Sirtex Medical
Segment by Type
Trans-Arterial Embolization (TAE)
Drug-Eluting Bead Chemoembolization (DEB-TACE)
Radioembolization (RE)
Others
Segment by Application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor Embolization company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Embolization Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Trans-Arterial Embolization (TAE)
1.2.3 Drug-Eluting Bead Chemoembolization (DEB-TACE)
1.2.4 Radioembolization (RE)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Tumor Embolization Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor Embolization Market Perspective (2020-2031)
2.2 Global Tumor Embolization Growth Trends by Region
2.2.1 Global Tumor Embolization Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Tumor Embolization Historic Market Size by Region (2020-2025)
2.2.3 Tumor Embolization Forecasted Market Size by Region (2026-2031)
2.3 Tumor Embolization Market Dynamics
2.3.1 Tumor Embolization Industry Trends
2.3.2 Tumor Embolization Market Drivers
2.3.3 Tumor Embolization Market Challenges
2.3.4 Tumor Embolization Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Embolization Players by Revenue
3.1.1 Global Top Tumor Embolization Players by Revenue (2020-2025)
3.1.2 Global Tumor Embolization Revenue Market Share by Players (2020-2025)
3.2 Global Tumor Embolization Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Tumor Embolization Revenue
3.4 Global Tumor Embolization Market Concentration Ratio
3.4.1 Global Tumor Embolization Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Embolization Revenue in 2024
3.5 Global Key Players of Tumor Embolization Head office and Area Served
3.6 Global Key Players of Tumor Embolization, Product and Application
3.7 Global Key Players of Tumor Embolization, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Embolization Breakdown Data by Type
4.1 Global Tumor Embolization Historic Market Size by Type (2020-2025)
4.2 Global Tumor Embolization Forecasted Market Size by Type (2026-2031)
5 Tumor Embolization Breakdown Data by Application
5.1 Global Tumor Embolization Historic Market Size by Application (2020-2025)
5.2 Global Tumor Embolization Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Tumor Embolization Market Size (2020-2031)
6.2 North America Tumor Embolization Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Tumor Embolization Market Size by Country (2020-2025)
6.4 North America Tumor Embolization Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tumor Embolization Market Size (2020-2031)
7.2 Europe Tumor Embolization Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Tumor Embolization Market Size by Country (2020-2025)
7.4 Europe Tumor Embolization Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor Embolization Market Size (2020-2031)
8.2 Asia-Pacific Tumor Embolization Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Tumor Embolization Market Size by Region (2020-2025)
8.4 Asia-Pacific Tumor Embolization Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tumor Embolization Market Size (2020-2031)
9.2 Latin America Tumor Embolization Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Tumor Embolization Market Size by Country (2020-2025)
9.4 Latin America Tumor Embolization Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor Embolization Market Size (2020-2031)
10.2 Middle East & Africa Tumor Embolization Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Tumor Embolization Market Size by Country (2020-2025)
10.4 Middle East & Africa Tumor Embolization Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boston Scientific Corporation
11.1.1 Boston Scientific Corporation Company Details
11.1.2 Boston Scientific Corporation Business Overview
11.1.3 Boston Scientific Corporation Tumor Embolization Introduction
11.1.4 Boston Scientific Corporation Revenue in Tumor Embolization Business (2020-2025)
11.1.5 Boston Scientific Corporation Recent Development
11.2 Varian Medical Systems, Inc.
11.2.1 Varian Medical Systems, Inc. Company Details
11.2.2 Varian Medical Systems, Inc. Business Overview
11.2.3 Varian Medical Systems, Inc. Tumor Embolization Introduction
11.2.4 Varian Medical Systems, Inc. Revenue in Tumor Embolization Business (2020-2025)
11.2.5 Varian Medical Systems, Inc. Recent Development
11.3 Nordion (Sotera Health)
11.3.1 Nordion (Sotera Health) Company Details
11.3.2 Nordion (Sotera Health) Business Overview
11.3.3 Nordion (Sotera Health) Tumor Embolization Introduction
11.3.4 Nordion (Sotera Health) Revenue in Tumor Embolization Business (2020-2025)
11.3.5 Nordion (Sotera Health) Recent Development
11.4 Sirtex Medical
11.4.1 Sirtex Medical Company Details
11.4.2 Sirtex Medical Business Overview
11.4.3 Sirtex Medical Tumor Embolization Introduction
11.4.4 Sirtex Medical Revenue in Tumor Embolization Business (2020-2025)
11.4.5 Sirtex Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Tumor Embolization Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Trans-Arterial Embolization (TAE)
Table 3. Key Players of Drug-Eluting Bead Chemoembolization (DEB-TACE)
Table 4. Key Players of Radioembolization (RE)
Table 5. Key Players of Others
Table 6. Global Tumor Embolization Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Tumor Embolization Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Tumor Embolization Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Tumor Embolization Market Share by Region (2020-2025)
Table 10. Global Tumor Embolization Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Tumor Embolization Market Share by Region (2026-2031)
Table 12. Tumor Embolization Market Trends
Table 13. Tumor Embolization Market Drivers
Table 14. Tumor Embolization Market Challenges
Table 15. Tumor Embolization Market Restraints
Table 16. Global Tumor Embolization Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Tumor Embolization Market Share by Players (2020-2025)
Table 18. Global Top Tumor Embolization Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Embolization as of 2024)
Table 19. Ranking of Global Top Tumor Embolization Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Tumor Embolization Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Tumor Embolization, Headquarters and Area Served
Table 22. Global Key Players of Tumor Embolization, Product and Application
Table 23. Global Key Players of Tumor Embolization, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Tumor Embolization Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Tumor Embolization Revenue Market Share by Type (2020-2025)
Table 27. Global Tumor Embolization Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Tumor Embolization Revenue Market Share by Type (2026-2031)
Table 29. Global Tumor Embolization Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Tumor Embolization Revenue Market Share by Application (2020-2025)
Table 31. Global Tumor Embolization Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Tumor Embolization Revenue Market Share by Application (2026-2031)
Table 33. North America Tumor Embolization Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Tumor Embolization Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Tumor Embolization Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Tumor Embolization Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Tumor Embolization Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Tumor Embolization Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Tumor Embolization Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Tumor Embolization Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Tumor Embolization Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Tumor Embolization Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Tumor Embolization Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Tumor Embolization Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Tumor Embolization Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Tumor Embolization Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Tumor Embolization Market Size by Country (2026-2031) & (US$ Million)
Table 48. Boston Scientific Corporation Company Details
Table 49. Boston Scientific Corporation Business Overview
Table 50. Boston Scientific Corporation Tumor Embolization Product
Table 51. Boston Scientific Corporation Revenue in Tumor Embolization Business (2020-2025) & (US$ Million)
Table 52. Boston Scientific Corporation Recent Development
Table 53. Varian Medical Systems, Inc. Company Details
Table 54. Varian Medical Systems, Inc. Business Overview
Table 55. Varian Medical Systems, Inc. Tumor Embolization Product
Table 56. Varian Medical Systems, Inc. Revenue in Tumor Embolization Business (2020-2025) & (US$ Million)
Table 57. Varian Medical Systems, Inc. Recent Development
Table 58. Nordion (Sotera Health) Company Details
Table 59. Nordion (Sotera Health) Business Overview
Table 60. Nordion (Sotera Health) Tumor Embolization Product
Table 61. Nordion (Sotera Health) Revenue in Tumor Embolization Business (2020-2025) & (US$ Million)
Table 62. Nordion (Sotera Health) Recent Development
Table 63. Sirtex Medical Company Details
Table 64. Sirtex Medical Business Overview
Table 65. Sirtex Medical Tumor Embolization Product
Table 66. Sirtex Medical Revenue in Tumor Embolization Business (2020-2025) & (US$ Million)
Table 67. Sirtex Medical Recent Development
Table 68. Research Programs/Design for This Report
Table 69. Key Data Information from Secondary Sources
Table 70. Key Data Information from Primary Sources
Table 71. Authors List of This Report


List of Figures
Figure 1. Tumor Embolization Picture
Figure 2. Global Tumor Embolization Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Tumor Embolization Market Share by Type: 2024 VS 2031
Figure 4. Trans-Arterial Embolization (TAE) Features
Figure 5. Drug-Eluting Bead Chemoembolization (DEB-TACE) Features
Figure 6. Radioembolization (RE) Features
Figure 7. Others Features
Figure 8. Global Tumor Embolization Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Tumor Embolization Market Share by Application: 2024 VS 2031
Figure 10. Hospitals Case Studies
Figure 11. Ambulatory Surgical Centers Case Studies
Figure 12. Specialty Clinics Case Studies
Figure 13. Others Case Studies
Figure 14. Tumor Embolization Report Years Considered
Figure 15. Global Tumor Embolization Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Tumor Embolization Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Tumor Embolization Market Share by Region: 2024 VS 2031
Figure 18. Global Tumor Embolization Market Share by Players in 2024
Figure 19. Global Top Tumor Embolization Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Embolization as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Tumor Embolization Revenue in 2024
Figure 21. North America Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Tumor Embolization Market Share by Country (2020-2031)
Figure 23. United States Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Tumor Embolization Market Share by Country (2020-2031)
Figure 27. Germany Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Tumor Embolization Market Share by Region (2020-2031)
Figure 35. China Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Tumor Embolization Market Share by Country (2020-2031)
Figure 43. Mexico Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Tumor Embolization Market Share by Country (2020-2031)
Figure 47. Turkey Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Tumor Embolization Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Boston Scientific Corporation Revenue Growth Rate in Tumor Embolization Business (2020-2025)
Figure 51. Varian Medical Systems, Inc. Revenue Growth Rate in Tumor Embolization Business (2020-2025)
Figure 52. Nordion (Sotera Health) Revenue Growth Rate in Tumor Embolization Business (2020-2025)
Figure 53. Sirtex Medical Revenue Growth Rate in Tumor Embolization Business (2020-2025)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies